What does aTENSION.life do?
aTENSION.life is a high-tech life science startup in Vienna developing precision diagnostics for hypertension using its proprietary ALDO+ platform.
How much did they raise?
The company raised USD 3M in Seed funding, led by Wlanholding with participation from eQventure and VP Venture Partners. Dr. Werner Lanthaler has been appointed Chairman of the Supervisory Board.
What are their plans for the money?
With the new funding, aTENSION.life plans to roll out its ALDO+PA test across the DACH markets by 2026 and expand into Germany, Switzerland, and the US, potentially transforming the diagnosis and management of hypertension.
What have they achieved so far?
The company has already launched its ALDO+PA test in Austria in partnership with labors.at and has early implementations in Germany, Switzerland, and the US.
